Korean drugs increase share in gastritis drug market

Published: 2012-01-26 06:59:00

Updated: 2012-01-26 06:59:00

Korean-made gastritis drugs accounted for a larger portion of the sector's domestic sales last year, an industry report showed recently.

According to Yakup.com, an information company, Dong-A Pharmaceutical's Stillen and Daewoong Pharmaceutical’s Albis posted 79.4 billion won and 47.4 billion...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK